2021-08-23 Sale | 2021-08-25 7:42 pm | Cullinan Oncology Inc. | CGEM | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner | 105,894 | $29.29 | $3,101,344 | 7,805,483 (Direct) | View |
2021-08-11 Sale | 2021-08-12 4:55 pm | Cullinan Oncology Inc. | CGEM | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner | 2,510 | $29.05 | $72,916 | 7,911,377 (Direct) | View |
2021-05-28 Sale | 2021-06-02 6:09 pm | Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner | 57,494 | $20.63 | $1,186,190 | 6,328,095 (Indirect) | View |
2021-05-26 Sale | 2021-05-27 7:40 pm | Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner | 17,159 | $20.22 | $346,938 | 6,385,589 (Indirect) | View |
2021-05-21 Sale | 2021-05-24 8:11 pm | Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner | 15,907 | $20.18 | $321,030 | 6,402,748 (Indirect) | View |
2021-05-18 Sale | 2021-05-20 7:20 pm | Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner | 47,948 | $20.49 | $982,227 | 6,418,655 (Indirect) | View |
2021-05-13 Sale | 2021-05-17 5:23 pm | Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner | 16,421 | $20.05 | $329,314 | 6,466,603 (Indirect) | View |
2021-05-10 Sale | 2021-05-12 6:09 pm | Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner | 68,262 | $21.04 | $1,436,556 | 6,483,024 (Indirect) | View |
2021-05-04 Purchase | 2021-05-06 4:19 pm | Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Innovations Fund GP LLC MPM Oncology Impact Management GP LLC 10% Owner | 245,000 | $16 | $3,920,000 | 6,672,183 (Indirect) | View |
2021-05-05 Sale | 2021-05-06 4:05 pm | Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner | 10,172 | $22.52 | $229,107 | 6,551,286 (Indirect) | View |
2021-04-30 Sale | 2021-05-04 5:43 pm | Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner | 328,519 | $22.48 | $7,386,435 | 6,561,458 (Indirect) | View |
2021-04-27 Sale | 2021-04-29 5:46 pm | Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner | 130,143 | $21.99 | $2,861,368 | 6,889,977 (Indirect) | View |
2021-04-21 Sale | 2021-04-22 4:04 pm | Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner | 8,972 | $18.97 | $170,229 | 7,020,120 (Indirect) | View |
2021-04-16 Sale | 2021-04-20 6:07 pm | Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner | 38,152 | $19.04 | $726,550 | 7,029,092 (Indirect) | View |
2021-04-13 Sale | 2021-04-15 8:00 pm | Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner | 38,556 | $20.16 | $777,359 | 7,067,244 (Indirect) | View |
2021-04-09 Sale | 2021-04-13 4:15 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. MPM Oncology Impact Management LP Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC 10% Owner | 200 | $29.99 | $5,998 | 6,004,368 (Indirect) | View |
2021-04-09 Sale | 2021-04-13 4:13 pm | Harpoon Therapeutics Inc. | HARP | GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner | 30,928 | $21.9 | $677,357 | 7,105,800 (Indirect) | View |
2021-04-07 Sale | 2021-04-09 4:47 pm | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. MPM Oncology Impact Management LP Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC 10% Owner | 41,982 | $30.99 | $1,300,850 | 6,020,238 (Indirect) | View |
2021-01-12 Purchase | 2021-01-14 5:54 pm | Cullinan Management Inc. | CGEM | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner | 300,000 | $21 | $6,300,000 | 7,913,887 (Direct) | View |
2020-10-06 Purchase | 2020-10-08 6:26 pm | Oncorus Inc. | ONCR | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner | 151,224 | $15 | $2,268,360 | 2,377,025 (Direct) | View |
2020-07-28 Purchase | 2020-07-30 08:00 am | iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP Oncology Impact Fund (Cayman) Management L.P. Director 10% Owner | 320,000 | $19 | $6,080,000 | 2,355,557 (Indirect) | View |